For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $73.46 in the prior trading day, Soleno Therapeutics Inc (NASDAQ: SLNO) closed at $75.07, up 2.19%. In other words, the price has increased by $2.19 from its previous closing price. On the day, 0.56 million shares were traded.
Ratios:
Our goal is to gain a better understanding of SLNO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.64 and its Current Ratio is at 19.64. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.22.
On December 02, 2024, Stifel reiterated its Buy ratingand also kept the price unchanged to $74.
Robert W. Baird reiterated its Outperform rating for the stock on December 02, 2024, and also maintained the target price at $72.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when Hirano Patricia C sold 3,782 shares for $70.11 per share. The transaction valued at 265,156 led to the insider holds 27,036 shares of the business.
PATRICIA HIRANO bought 3,782 shares of SLNO for $265,156 on Apr 01 ’25. On Mar 28 ’25, another insider, Pauls Matthew, who serves as the Director of the company, sold 5,937 shares for $71.55 each. As a result, the insider received 424,797 and left with 6,500 shares of the company.
Stock Price History:
Over the past 52 weeks, SLNO has reached a high of $80.99, while it has fallen to a 52-week low of $36.93. The 50-Day Moving Average of the stock is 16.40%, while the 200-Day Moving Average is calculated to be 40.54%.
Shares Statistics:
A total of 48.53M shares are outstanding, with a floating share count of 41.28M. Insiders hold about 18.09% of the company’s shares, while institutions hold 91.07% stake in the company.
